RO-47-1816/001

N/A

Report date: 2025/01/15 16:59:50
NME

Base Information

Drug NameRO-47-1816/001
Drug Alias NameRO-47-1816/001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmyloid inhibitors
TargetsAmyloid
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ag
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A